Skip to content

Therapy of Peri-implantitis: Scaling Versus Low Abrasive Powder

A Randomized Multicenter Study in the Therapy of Periimplantitis: Scaling Versus Low Abrasive Powder

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01256996
Enrollment
40
Registered
2010-12-09
Start date
2011-01-31
Completion date
2012-01-31
Last updated
2010-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-implantitis

Brief summary

In the last decade, the number of dental implantations continuously increases. However, at the same time, the prevalence of peri-implantitis increases, too. Although both surgical and non-surgical interventions are available for the therapy, there is no efficient and satisfying therapy option resulting in an adequate improvement of this disease. An innovative, low abrasive powder has been introduced for the therapy of periodontitis. However, the powder might be suitable for the peri-implantitis therapy, also, and could improve the effectiveness of the therapy. The usage of this powder in peri-implantitis patients has not been assessed in a clinical trial although the effectiveness in natural teeth has been demonstrated. The aim of this prospective, randomised, multi-centre trial is to assess the effectiveness of the aforementioned powder in peri-implantitis patients.

Interventions

PROCEDUREAir abrasion of the implant surface with a low abrasive powder

Test treatment will be performed using the low abrasive powder in a standard air-polishing unit, which will be set up according to the manufacturer's instructions. The unit will be set to a medium water and powder setting, and the powder chamber will be filled to the indicated maximum powder level before treatment to ensure reproducible treatment conditions. The jet will be directed to the periodontal pocket for 5 s per surface (vestibular, lingual, mesio and distal) for subgingival plaque removal.

Sponsors

Heidelberg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Mild to moderate peri-implantitis * age ≥18 years * capacity to contract * no subgingival debridement within the last six months * informed consent

Exclusion criteria

* pregnancy * subgingival debridement within the last six months * bleeding tendency * usage of antibiotics within the last three months * insufficient restorations (including caries etc.) * Diabetes mellitus * smoker * implantats with platform switch

Design outcomes

Primary

MeasureTime frame
Pocket probing depthTwelve months

Secondary

MeasureTime frame
Assessment of pain levelsOne week and six months
Assessment of the oral health related quality of life using the OHIP (14)One , three, six and twelve months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026